Your browser doesn't support javascript.
loading
Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study.
Queirolo, Paola; Dozin, Beatrice; Morabito, Anna; Banelli, Barbara; Piccioli, Patrizia; Fava, Cristiana; Leo, Claudio; Carosio, Roberta; Laurent, Stefania; Fontana, Vincenzo; Ferrucci, Pier Francesco; Martinoli, Chiara; Cocorocchio, Emilia; Battaglia, Angelo; Ascierto, Paolo A; Capone, Mariaelena; Simeone, Ester; De Galitiis, Federica; Pagani, Elena; Antonini Cappellini, Gian Carlo; Marchetti, Paolo; Guida, Michele; Tommasi, Stefania; Mandalà, Mario; Merelli, Barbara; Quaglino, Pietro; Fava, Paolo; Guidoboni, Massimo; Romani, Massimo; Spagnolo, Francesco; Pistillo, Maria Pia.
Afiliação
  • Queirolo P; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
  • Dozin B; Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
  • Morabito A; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
  • Banelli B; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
  • Piccioli P; Department of Health Sciences, University of Genova, Genova, Italy.
  • Fava C; Unit of Cellular Biology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
  • Leo C; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
  • Carosio R; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
  • Laurent S; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
  • Fontana V; Intergruppo Melanoma Italiano (IMI) and Department of Internal Medicine, University of Genova, Genova, Italy.
  • Ferrucci PF; Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
  • Martinoli C; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy.
  • Cocorocchio E; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy.
  • Battaglia A; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy.
  • Ascierto PA; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy.
  • Capone M; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy.
  • Simeone E; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy.
  • De Galitiis F; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy.
  • Pagani E; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy.
  • Antonini Cappellini GC; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy.
  • Marchetti P; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy.
  • Guida M; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy.
  • Tommasi S; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Mandalà M; Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II,"Bari, Italy.
  • Merelli B; Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II,"Bari, Italy.
  • Quaglino P; Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Fava P; Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Guidoboni M; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Romani M; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Spagnolo F; Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy.
  • Pistillo MP; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Front Immunol ; 9: 403, 2018.
Article em En | MEDLINE | ID: mdl-29531523
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Immunol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália